title: [Badly controlled severe persistent asthma: an additional new treatment].
authors.affiliation: Hôpital Antonie Béclère, Paris.
authors.forename: Legendre
authors.initials: L
authors.lastname: Nomémie
authors.forename: Marie-Pascale
authors.initials: MP
authors.lastname: Verpilleux
authors.forename: Karine
authors.initials: K
authors.lastname: Ballouard
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000069444:Omalizumab; D012720:Severity of Illness Index
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab